157 related articles for article (PubMed ID: 16507425)
1. Mechanistic insights into achievement of cardiac allograft long-term survival by treatment with immature dendritic cells and sub-dose sirolimus.
Tao R; Wang L; Chen CH; Wang SH; Demarco RA; Lotze MT; Thai NL; Fung JJ; Lu L; Qian S
J Heart Lung Transplant; 2006 Mar; 25(3):310-9. PubMed ID: 16507425
[TBL] [Abstract][Full Text] [Related]
2. Application of recipient-derived dendritic cells to induce donor-specific T-cell hyporesponsiveness.
Tiao MM; Lu L; Tao R; Harnaha J; Fung JJ; Huang LT; Qian S
Transplant Proc; 2004 Jun; 36(5):1592-4. PubMed ID: 15251391
[TBL] [Abstract][Full Text] [Related]
3. Administration of antisense oligodeoxyribonucleotides targeting NF-kappaB prolongs allograft survival via suppression of cytotoxicity.
Chen Z; Lu L; Zhang H; Dean NM; Fung JJ; Qian S
Microsurgery; 2003; 23(5):494-7. PubMed ID: 14558009
[TBL] [Abstract][Full Text] [Related]
4. Prolongation of cardiac allograft survival using dendritic cells treated with NF-kB decoy oligodeoxyribonucleotides.
Giannoukakis N; Bonham CA; Qian S; Chen Z; Peng L; Harnaha J; Li W; Thomson AW; Fung JJ; Robbins PD; Lu L
Mol Ther; 2000 May; 1(5 Pt 1):430-7. PubMed ID: 10933964
[TBL] [Abstract][Full Text] [Related]
5. Prolongation of cardiac allograft survival by systemic administration of immature recipient dendritic cells deficient in NF-kappaB activity.
Tiao MM; Lu L; Tao R; Wang L; Fung JJ; Qian S
Ann Surg; 2005 Mar; 241(3):497-505. PubMed ID: 15729074
[TBL] [Abstract][Full Text] [Related]
6. Administration of dendritic cells transduced with antisense oligodeoxyribonucleotides targeting CD80 or CD86 prolongs allograft survival.
Liang X; Lu L; Chen Z; Vickers T; Zhang H; Fung JJ; Qian S
Transplantation; 2003 Aug; 76(4):721-9. PubMed ID: 12973117
[TBL] [Abstract][Full Text] [Related]
7. TGF-beta(1) gene modified immature dendritic cells exhibit enhanced tolerogenicity but induce allograft fibrosis in vivo.
Sun W; Wang Q; Zhang L; Pan J; Zhang M; Lu G; Yao H; Wang J; Cao X
J Mol Med (Berl); 2002 Aug; 80(8):514-23. PubMed ID: 12185452
[TBL] [Abstract][Full Text] [Related]
8. Blockade of CD40 pathway enhances the induction of immune tolerance by immature dendritic cells genetically modified to express cytotoxic T lymphocyte antigen 4 immunoglobulin.
Sun W; Wang Q; Zhang L; Liu Y; Zhang M; Wang C; Wang J; Cao X
Transplantation; 2003 Nov; 76(9):1351-9. PubMed ID: 14627915
[TBL] [Abstract][Full Text] [Related]
9. Long-term survival of limb allografts induced by pharmacologically conditioned, donor alloantigen-pulsed dendritic cells without maintenance immunosuppression.
Ikeguchi R; Sacks JM; Unadkat JV; Solari M; Horibe EK; Thomson AW; Lee AW; Feili-Hariri M
Transplantation; 2008 Jan; 85(2):237-46. PubMed ID: 18212629
[TBL] [Abstract][Full Text] [Related]
10. Marked prolongation of cardiac allograft survival by dendritic cells genetically engineered with NF-kappa B oligodeoxyribonucleotide decoys and adenoviral vectors encoding CTLA4-Ig.
Bonham CA; Peng L; Liang X; Chen Z; Wang L; Ma L; Hackstein H; Robbins PD; Thomson AW; Fung JJ; Qian S; Lu L
J Immunol; 2002 Sep; 169(6):3382-91. PubMed ID: 12218160
[TBL] [Abstract][Full Text] [Related]
11. Control of allograft rejection by applying a novel nuclear factor-kappaB inhibitor, dehydroxymethylepoxyquinomicin.
Ueki S; Yamashita K; Aoyagi T; Haga S; Suzuki T; Itoh T; Taniguchi M; Shimamura T; Furukawa H; Ozaki M; Umezawa K; Todo S
Transplantation; 2006 Dec; 82(12):1720-7. PubMed ID: 17198266
[TBL] [Abstract][Full Text] [Related]
12. Decoy NF-kappaB fortified immature dendritic cells maintain laryngeal allograft integrity and provide enhancement of regulatory T cells.
Lott DG; Dan O; Lu L; Strome M
Laryngoscope; 2010 Jan; 120(1):44-52. PubMed ID: 19877191
[TBL] [Abstract][Full Text] [Related]
13. Free bone graft attenuates acute rejection and in combination with cyclosporin a leads to indefinite cardiac allograft survival.
Wang H; Ge W; Arp J; Zassoko R; Liu W; Ichim TE; Jiang J; Jevnikar AM; Garcia B
J Immunol; 2009 May; 182(10):5970-81. PubMed ID: 19414748
[TBL] [Abstract][Full Text] [Related]
14. Rapamycin-conditioned, alloantigen-pulsed dendritic cells promote indefinite survival of vascularized skin allografts in association with T regulatory cell expansion.
Horibe EK; Sacks J; Unadkat J; Raimondi G; Wang Z; Ikeguchi R; Marsteller D; Ferreira LM; Thomson AW; Lee WP; Feili-Hariri M
Transpl Immunol; 2008 Feb; 18(4):307-18. PubMed ID: 18158116
[TBL] [Abstract][Full Text] [Related]
15. Immunosuppressive and trafficking properties of donor splenic and bone marrow dendritic cells.
Emmanouilidis N; Guo Z; Dong Y; Newton-West M; Adams AB; Lee ED; Wang J; Pearson TC; Larsen CP; Newell KA
Transplantation; 2006 Feb; 81(3):455-62. PubMed ID: 16477234
[TBL] [Abstract][Full Text] [Related]
16. Prolongation of skin graft survival by modulation of the alloimmune response with alternatively activated dendritic cells.
Roelen DL; Schuurhuis DH; van den Boogaardt DE; Koekkoek K; van Miert PP; van Schip JJ; Laban S; Rea D; Melief CJ; Offringa R; Ossendorp F; Claas FH
Transplantation; 2003 Dec; 76(11):1608-15. PubMed ID: 14702533
[TBL] [Abstract][Full Text] [Related]
17. Mechanistic insights into impaired dendritic cell function by rapamycin: inhibition of Jak2/Stat4 signaling pathway.
Chiang PH; Wang L; Bonham CA; Liang X; Fung JJ; Lu L; Qian S
J Immunol; 2004 Feb; 172(3):1355-63. PubMed ID: 14734710
[TBL] [Abstract][Full Text] [Related]
18. Administration of dendritic cells modified by RNA interference prolongs cardiac allograft survival.
Xiang J; Gu X; Zhou Y; Gong X; Qian S; Chen Z
Microsurgery; 2007; 27(4):320-3. PubMed ID: 17477425
[TBL] [Abstract][Full Text] [Related]
19. Induction of regulatory dendritic cells by topical application of NF-kappaB decoy oligodeoxynucleotides.
Isomura I; Shintani Y; Yasuda Y; Tsujimura K; Morita A
Immunol Lett; 2008 Aug; 119(1-2):49-56. PubMed ID: 18547648
[TBL] [Abstract][Full Text] [Related]
20. [Inhibition of nuclear translocation and binding activity of nuclear factor-kappaB by oligodeoxynucleotides in THP-1 cells].
Cui ZL; Zhou J
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jan; 26(1):102-4. PubMed ID: 16495188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
